In our analysis, we also discovered changes in the immune microenvironment, the key immune cells (B cells, DCs, MAIT cells) and genes (AKR1B10, SPP1) in the progression of NAFLD. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatotic liver disease.